ArticleOncology letters2018

Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma.

Wenting Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.